ANTI-OBESITY PHARMACOLOGICAL AGENTS FOR POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS TO INFORM THE 2023 INTERNATIONAL EVIDENCE-BASED GUIDELINE